Results 241 to 250 of about 724,197 (388)

Evaluation of heparin gel's effects on stage II pressure ulcers: a randomized controlled trial. [PDF]

Eur J Med Res
Khani R, Behbood L, Fallahi M, Rezaeian S, Shahbazi F.   +4 more
europepmc   +1 more source

Prognostic Value of Lupus Anticoagulant and Anti–β2 Glycoprotein I Antibody in Adverse Pregnancy Outcomes

Arthritis &Rheumatology, EarlyView.
Objective International criteria for antiphospholipid syndrome (APS) include lupus anticoagulant (LA), anticardiolipin (aCL) IgG and IgM, and anti–β2‐glycoprotein I (β2GPI) IgG and IgM. However, evidence supporting their prognostic value or treatment efficacy in improving live birth rates is limited.
Megumi Nonobe, Takahiro Otani, Hiroyuki Yoshihara, Shinobu Goto, Tamao Kitaori, Naomi Nishikawa, Yuichiro Fujieda, Tatsuya Atsumi, Mayumi Sugiura‐Ogasawara   +8 more
wiley   +1 more source

Spontaneous Heparin-Induced Thrombocytopenia Following Orthopedic Surgery. [PDF]

Cureus
Korolyov A, Hu R.
europepmc   +1 more source

The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. [PDF]

, 1995
Shigeki Higashiyama, Ryo Iwamoto, K. Goishi, Gerhard Raab, Naoyuki Taniguchi, Michael Klagsbrun, Eisuke Mekada   +6 more
openalex   +1 more source

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.

, 1997
M. Cohen, C. Demers, E. Gurfinkel, A. Turpie, G. Fromell, S. Goodman, A. Langer, R. Califf, K. Fox, J. Premmereur, F. Bigonzi, Jim Stephens, B. Weatherley   +12 more
semanticscholar   +1 more source

Nationwide temporal trends in adverse pregnancy outcomes and treatments in systemic lupus erythematosus pregnancy over two decades in Sweden

Arthritis &Rheumatology, Accepted Article.
Objective This nationwide descriptive study examined temporal trends in adverse pregnancy outcomes (APOs) and treatments in systemic lupus erythematosus (SLE) pregnancies in Sweden over 2003‐2022. Methods Using nationwide Swedish registers, we identified 1,417 pregnancies of women with prevalent SLE and delivery dates in 2003‐2022, and matched them to ...
Ngoc V. Nguyen, Anna Sandström, Annica Dominicus, Elisabet Svenungsson, Karin Hellgren, Julia F. Simard, Elizabeth V. Arkema   +6 more
wiley   +1 more source

Effect of early prophylactic heparin use on prognosis in critically ill patients with acute pancreatitis: a retrospective cohort study. [PDF]

Sci Rep
Ding Y, Zhao Y, Bai X, Lu J, Gao B, Yuan Y, Yang X, Li B.   +7 more
europepmc   +1 more source

Argatroban as a substitute for heparin during VAIVT for a patient with heparin-induced thrombocytopenia

, 2018
Kenji Sangawa, Takashi Sekikawa
openalex   +2 more sources

Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Chest, 2012
L. Linkins, A. Dans, Lisa K. Moores, Robert Bona, Bruce L Davidson, S. Schulman, Mark Crowther   +6 more
semanticscholar   +1 more source

Translation of a physiologically‐based pharmacokinetic model for dabigatran etexilate to the design of a safety and efficacy study in post‐partum women

British Journal of Clinical Pharmacology, EarlyView.
Aims To translate a PBPK model developed for the direct oral anticoagulant, dabigatran etexilate, the prodrug of dabigatran, based on data obtained from healthy men to healthy non‐pregnant, pregnant and post‐partum women. To evaluate safety and efficacy of dabigatran etexilate in post‐partum women using simulations and design a future clinical study to
Kayode Ogungbenro, Lorna Aucott, Farhad Kamali, Paul Ayuk   +3 more
wiley   +1 more source